USPTO trademark

FREXIWAY

Awaiting publicationUSPTOWord markClass 5

"FREXIWAY" is a word mark owned by Sanofi, filed at the USPTO on April 8, 2026. It is waiting to be published and covers class 5 (Pharmaceuticals).

View Sanofi portfolioGet this data via the API
Official USPTO record
FREXIWAY trademark as filed
As filed with the USPTO
Status
Awaiting publication
Since October 28, 2026
Filed
April 8, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99750796
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns FREXIWAY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Sanofi

Paris, France

3,998 trademarks in the portfolioView company

Representative

Alexandra Kochian

Fross Zelnick Lehrman & Zissu, P.C.

Goods and services

What the mark covers

The products and services FREXIWAY is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment and prevention of autoimmune, immune-mediated, inflammatory and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the central nervous system; Pharmaceutical preparations for the treatment and prevention of rare autoimmune, immune-mediated, inflammatory, immunological, central nervous system and neurological diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Approved for pub - principal register
  2. Teas/email correspondence entered
  3. Correspondence received in law office
  4. Teas response to suspension inquiry received
  5. Notification of letter of suspension e-mailed
  6. Letter of suspension e-mailed
  7. Suspension letter written
  8. Assigned to examiner
  9. Application filing receipt mailed
  10. New application office supplied data entered

1 earlier step on the official record.

FAQ

About FREXIWAY

Who owns the trademark "FREXIWAY"?

The USPTO trademark "FREXIWAY" (application 99750796) is owned by Sanofi.

What is the status of "FREXIWAY"?

Its status at the USPTO is: awaiting publication.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull FREXIWAY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d7a2e-8f43-71ee-80d1-7d3dca72bb2c
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d7a2e-8f43-71ee-80d1-7d3dca72bb2c",
  "object": "trademark",
  "mark_text": "FREXIWAY",
  "status": {
    "primary": "pending",
    "stage": "pending_publication"
  },
  "office_code": "US",
  "application_number": "99750796",
  "filing_date": "2026-04-08",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Sanofi",
      "entity_id": "ent_019eb6f6-62f9-773d-a835-46d137e82556"
    }
  ]
}